The Lancet最新文献

筛选
英文 中文
Whither public health? | Tom Frieden, The Formula for Better Health: How to Save Millions of Lives—Including Your Own, The MIT Press (2025), p. 288, US$29·95, ISBN: 9780262050968 公共卫生何去何从?|汤姆·弗里登,《改善健康的公式:如何拯救数百万人的生命——包括你自己的生命》,麻省理工学院出版社(2025),288页,29.95美元,ISBN: 9780262050968
The Lancet Pub Date : 2025-09-25 DOI: 10.1016/s0140-6736(25)01914-2
Sandro Galea
{"title":"Whither public health? | Tom Frieden, The Formula for Better Health: How to Save Millions of Lives—Including Your Own, The MIT Press (2025), p. 288, US$29·95, ISBN: 9780262050968","authors":"Sandro Galea","doi":"10.1016/s0140-6736(25)01914-2","DOIUrl":"https://doi.org/10.1016/s0140-6736(25)01914-2","url":null,"abstract":"No Abstract","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eleanor Maguire 埃莉诺·马奎尔
The Lancet Pub Date : 2025-09-25 DOI: 10.1016/s0140-6736(25)01916-6
Georgina Ferry
{"title":"Eleanor Maguire","authors":"Georgina Ferry","doi":"10.1016/s0140-6736(25)01916-6","DOIUrl":"https://doi.org/10.1016/s0140-6736(25)01916-6","url":null,"abstract":"<span><figure><span><img alt=\"\" height=\"428\" src=\"https://ars.els-cdn.com/content/image/1-s2.0-S0140673625019166-fx1.jpg\"/><ol><li><span><span>Download: <span>Download high-res image (317KB)</span></span></span></li><li><span><span>Download: <span>Download full-size image</span></span></span></li></ol></span></figure></span>","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"53 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ivonescimab versus pembrolizumab in PD-L1-positive NSCLC – Authors' reply Ivonescimab与pembrolizumab在pd - l1阳性NSCLC中的对比——作者的答复
The Lancet Pub Date : 2025-09-25 DOI: 10.1016/s0140-6736(25)01588-0
Anwen Xiong, Lei Wang, Jianhua Chen, Lin Wu, Caicun Zhou
{"title":"Ivonescimab versus pembrolizumab in PD-L1-positive NSCLC – Authors' reply","authors":"Anwen Xiong, Lei Wang, Jianhua Chen, Lin Wu, Caicun Zhou","doi":"10.1016/s0140-6736(25)01588-0","DOIUrl":"https://doi.org/10.1016/s0140-6736(25)01588-0","url":null,"abstract":"No Abstract","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"73 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinical decision tool including a decision tree, point-of-care testing of CRP, and safety-netting advice to guide antibiotic prescribing in acutely ill children in primary care in Belgium (ARON): a pragmatic, cluster-randomised, controlled trial 一项临床决策工具,包括决策树、CRP的即时检测和安全网建议,以指导比利时初级保健急性病儿童的抗生素处方(ARON):一项实用的、集群随机对照试验
The Lancet Pub Date : 2025-09-25 DOI: 10.1016/s0140-6736(25)01239-5
Jan Yvan Verbakel, Ruben Burvenich, Erinn D'hulster, Liselore De Rop, Ann Van den Bruel, Sibyl Anthierens, Samuel Coenen, An De Sutter, Stefan Heytens, Louise Joly, Marina Digregorio, Annouschka Laenen, Jeroen Luyten, Tine De Burghgraeve
{"title":"A clinical decision tool including a decision tree, point-of-care testing of CRP, and safety-netting advice to guide antibiotic prescribing in acutely ill children in primary care in Belgium (ARON): a pragmatic, cluster-randomised, controlled trial","authors":"Jan Yvan Verbakel, Ruben Burvenich, Erinn D'hulster, Liselore De Rop, Ann Van den Bruel, Sibyl Anthierens, Samuel Coenen, An De Sutter, Stefan Heytens, Louise Joly, Marina Digregorio, Annouschka Laenen, Jeroen Luyten, Tine De Burghgraeve","doi":"10.1016/s0140-6736(25)01239-5","DOIUrl":"https://doi.org/10.1016/s0140-6736(25)01239-5","url":null,"abstract":"&lt;h3&gt;Background&lt;/h3&gt;Antimicrobial resistance is a global health threat. Many children with acute illness in ambulatory care are unnecessarily prescribed antibiotics. We assessed the clinical effectiveness of a clinical decision tool for these children, including a validated decision tree, guided point-of-care C-reactive protein testing (POCT of CRP), and safety-netting advice.&lt;h3&gt;Methods&lt;/h3&gt;ARON was a multicentre, unblinded, pragmatic, cluster-randomised, controlled trial conducted at eligibile Belgian general practitioner and community paediatrician practices able to recruit children with acute illness consecutively, and not already doing POCT of CRP. Practices were allocated (1:1) with equal size (n=4) block randomisation to the clinical decision tool or usual care, stratified by recruiting academic centre. Children with acute illness aged 6 months to 12 years were recruited and followed up for 30 days. The coprimary outcomes were antibiotic prescribing at the index consultation (tested for superiority), as well as recovery time, additional testing, follow-up visits, and antibiotic prescribing after index consultation (all tested for non-inferiority with margins of 1 day, 3%, 4%, and 2%, respectively). Coprimary outcomes were analysed with logistic regression, accounting for practice clustering, study arm, and age in the intention-to-treat population, except recovery time, which was analysed with Cox regression adjusting for the same covariates. Safety was assessed in the intention-to-treat population. This trial is registered with &lt;span&gt;&lt;span&gt;ClinicalTrials.gov&lt;/span&gt;&lt;svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"&gt;&lt;path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt; (&lt;span&gt;&lt;span&gt;NCT04470518&lt;/span&gt;&lt;svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"&gt;&lt;path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt;) and is completed.&lt;h3&gt;Findings&lt;/h3&gt;Of 171 eligible practices, we randomly allocated 82 to the intervention group and 89 to the usual care group. Between Feb 24, 2021, and Dec 29, 2023, 7049 participants were screened, of whom 6760 were deemed eligible. Five patients in each study arm were excluded, so we analysed data from 6750 participants (2988 in the intervention group and 3762 in the control group; 3447 [51%] boys, 3302 [49%] girls, one [&lt;1%] did not specify). The intervention significantly reduced antibiotic prescribing at the index consultation (466 [16%] &lt;em&gt;vs&lt;/em&gt; 817 [22%], adjusted odds ratio 0·72 [95% CI 0·55–0·94]; p=0·017). Recovery time (adjusted mean difference –0·1 day [95% CI –0·5 to 0·3]), additional testing (adjusted absolute risk reduction [aARR] 2·0% [–1·7 to 5·0]), follow-up visits (aARR 2·8% [–0·9 to 6·1]), and antibiotic prescribing after index consultation (aARR 2·4% [0·2 to 4·2]) were all non-inferior in the interven","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing just-in-case primary care antibiotic prescribing in children 减少儿童的即时初级保健抗生素处方
The Lancet Pub Date : 2025-09-25 DOI: 10.1016/s0140-6736(25)01336-4
Alastair D Hay, Emily Brown
{"title":"Reducing just-in-case primary care antibiotic prescribing in children","authors":"Alastair D Hay, Emily Brown","doi":"10.1016/s0140-6736(25)01336-4","DOIUrl":"https://doi.org/10.1016/s0140-6736(25)01336-4","url":null,"abstract":"No Abstract","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"69 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Offline: Research integrity—a challenge not a crisis 线下:研究诚信——一个挑战而不是危机
The Lancet Pub Date : 2025-09-25 DOI: 10.1016/s0140-6736(25)01943-9
Richard Horton
{"title":"Offline: Research integrity—a challenge not a crisis","authors":"Richard Horton","doi":"10.1016/s0140-6736(25)01943-9","DOIUrl":"https://doi.org/10.1016/s0140-6736(25)01943-9","url":null,"abstract":"No Abstract","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"91 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seeking connection 寻求连接
The Lancet Pub Date : 2025-09-25 DOI: 10.1016/s0140-6736(25)01915-4
Gabriel Weston
{"title":"Seeking connection","authors":"Gabriel Weston","doi":"10.1016/s0140-6736(25)01915-4","DOIUrl":"https://doi.org/10.1016/s0140-6736(25)01915-4","url":null,"abstract":"No Abstract","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Department of Error 错误部
The Lancet Pub Date : 2025-09-25 DOI: 10.1016/s0140-6736(25)01913-0
{"title":"Department of Error","authors":"","doi":"10.1016/s0140-6736(25)01913-0","DOIUrl":"https://doi.org/10.1016/s0140-6736(25)01913-0","url":null,"abstract":"<em>Frisoni GB, Aho E, Brayne C, et al. Alzheimer's disease outlook: controversies and future directions.</em> Lancet <em>2025; <strong>406:</strong> 1424–42</em>—In the Declaration of interests section of this Series paper, statements should have been included for Christopher C Rowe. These corrections have been made to the online version as of Sept 25, 2025, and the printed version is correct.","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atosiban for threatened preterm birth: the APOSTEL 8 trial – Authors' reply 阿托西班治疗先兆早产:APOSTEL 8试验——作者回复
The Lancet Pub Date : 2025-09-25 DOI: 10.1016/s0140-6736(25)01569-7
Larissa I van der Windt, Martijn A Oudijk
{"title":"Atosiban for threatened preterm birth: the APOSTEL 8 trial – Authors' reply","authors":"Larissa I van der Windt, Martijn A Oudijk","doi":"10.1016/s0140-6736(25)01569-7","DOIUrl":"https://doi.org/10.1016/s0140-6736(25)01569-7","url":null,"abstract":"No Abstract","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145141058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ivonescimab versus pembrolizumab in PD-L1-positive NSCLC Ivonescimab与pembrolizumab治疗pd - l1阳性NSCLC
The Lancet Pub Date : 2025-09-25 DOI: 10.1016/s0140-6736(25)01236-x
Mingyang Xue, Wenyi Jin
{"title":"Ivonescimab versus pembrolizumab in PD-L1-positive NSCLC","authors":"Mingyang Xue, Wenyi Jin","doi":"10.1016/s0140-6736(25)01236-x","DOIUrl":"https://doi.org/10.1016/s0140-6736(25)01236-x","url":null,"abstract":"No Abstract","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信